Journal List > Korean J Urol > v.49(7) > 1005144

Kwon, Woo, Kim, Lee, Kim, and Yun: Changes in Voiding Patterns after Transobturator Tape Operation in Female Patients with Stress Urinary Incontinence

Abstract

Purpose

A lot of patients with stress urinary incontinence (SUI) have lower urinary tract symptoms. So we evaluated the changes of voiding pattern following transobturator tape (TOT) operation, and investigated the factors for predicting persistent urinary frequency after operation.

Materials and Methods

The items of preoperative evaluations consisted of history taking, physical examination, cystometrography, 3 day frequency-volume chart and symptoms questionnaire. Patients with anticholinergics or any neurologic diseases that affect the voiding pattern were excluded. Between January to November 2006, 46 patients with TOT operation were enrolled, and were reevaluated with physical examination, 3 day frequency-volume chart and symptom questionnaires, postoperatively.

Results

The patients who voided 8 or more times per day had shorter symptom duration and higher body mass index (BMI) than those who voided under 8 times per day (each p<0.05). In 30 patients who void 8 or moretimes per day preoperatively, 17 (56.7%) patients became void under 8 times, postoperatively. In each patient who had urgency or urge incontinence symptoms preoperatively, respective 72.7 and 82.8% resolved their symptoms, postoperatively. No one complained de novo urgency or urge incontinence, postoperatively. In a multivariate analysis, the patient with a history of previous pelvic surgery or moderate to severe urge incontinence was tightly associated with an increased likelihood of persistent urinary frequency after TOT operation (odd ratio [OR] 24.8, 95% confidence interval [CI] 2.044-301.284, p=0.012 and OR 31.9, 95% CI 1.662-613.619, p=0.022, respectively).

Conclusions

The TOT operation can improve the symptoms of urinary frequency, urgency and urge incontinence in patients with SUI. However, the patients who had previous pelvic surgeriesor moderate to severe urge incontinence should be fully advised for the risk of sustaining frequency, postoperatively.

REFERENCES

1.Delorme E., Droupy S., de Tayrac R., Delmas V. Transobturator tape (Uratape): a new minimally-invasive procedure to treat female urinary incontinence. Eur Urol. 2004. 45:203–7.
crossref
2.Lee BG., Kim HS., Koh JS., Kim HW., Lee YS., Suh HJ, et al. The changes of storage symptoms after tension-free vaginal tape procedures in stress urinary incontinence patients. Korean J Urol. 2007. 48:1289–95.
crossref
3.Anger JT., Rodriguez LV. Mixed incontinence: stressing about urge. Curr Urol Rep. 2004. 5:427–31.
crossref
4.Sung VW., Schleinitz MD., Rardin CR., Ward RM., Myers DL. Comparison of retropubic vs transobturator approach to midurethral slings: a systematic review and meta-analysis. Am J Obstet Gynecol. 2007. 197:3–11.
crossref
5.Roumeguere T., Quackels T., Bollens R., de Groote A., Zlotta A., Bossche MV, et al. Trans-obturator vaginal tape (TOT) for female stress incontinence: one year follow-up in 120 patients. Eur Urol. 2005. 48:805–9.
crossref
6.Elinoff V., Bavendam T., Glasser DB., Carlsson M., Eyland N., Roberts R. Symptom-specific efficacy of tolterodine extended release in patients with overactive bladder: the IMPACT trial. Int J Clin Pract. 2006. 60:745–51.
crossref
7.Starkman JS., Dmochowski RR. Urgency assessment in the evaluation of overactive bladder (OAB). Neurourol Urodyn. 2008. 27:13–21.
crossref
8.Teleman PM., Lidfeldt J., Nerbrand C., Samsioe G., Mattiasson A. Overactive bladder: prevalence, risk factors and relation to stress incontinence in middle-aged women. BJOG. 2004. 111:600–4.
crossref
9.Hung MJ., Ho ES., Shen PS., Sun MJ., Lin AT., Chen GD. Urgency is the core symptom of female overactive bladder syndrome, as demonstrated by a statistical analysis. J Urol. 2006. 176:636–40.
crossref
10.Choe JH., Choo MS., Lee KS. The impact of tension-free vaginal tape on overactive bladder symptoms in women with stress urinary incontinence: significance of detrusor overactivity. J Urol. 2008. 179:214–9.
crossref
11.Ku JH., Shin JW., Son H., Oh SJ., Kim SW., Paick JS. Predictive factors for persistent urgency or urge incontinence after tension-free vaginal tape procedure in mixed urinary incontinence. Korean J Urol. 2004. 45:330–6.

Fig. 1.
Changes in the frequency scale.
kju-49-609f1.tif
Fig. 2.
Changes in the urgency scale.
kju-49-609f2.tif
Fig. 3.
Changes in the urge incontinence scale.
kju-49-609f3.tif
Table 1.
Comparison of clinical characteristics and parameters in relation to urinary frequency
Urinary frequency <8 (%) Urinary frequency ≥8 (%) p-value
No. of patients 16 30
Median age at 49.1 50.1
operation (range) (42.0-63.2) (30.8-73.5) 0.782*
Symptom duration 8.4±6.0 4.6±4.0 0.018*
SUI symptom grade 0.726
I 6 (37.58) 14 (46.7)
II 9 (56.3) 14 (46.7)
III 1 (6.3) 2 (6.7)
Pad apply 9 (56.3) 17 (56.7) 0.978
Parity 2.3±0.9 2.6±1.2 0.200*
Previous pelvic surgery 3 (18.8) 7 (23.3) 0.859
Postmenopause 5 (31.3) 13 (43.3) 0.424
BMI 23.7±2.5 25.6±2.9 0.042*
Maximum voided volume 388.8±145.0 347.7±83.2 0.031*
Q-tip test≥30o 10 (62.5) 17 (56.7) 0.702
VLPP<60cmH2O 3 (18.8) 9 (30.0) 0.498
Detrusor overactivity 1 (6.3) 9 (30.0) 0.130
Frequency scale <0.001
0 5 (31.3) 0 (0)
1 6 (37.5) 1 (3.3)
2 4 (25.0) 15 (50.0)
3 1 (6.3) 14 (46.7)
Urgency scale 0.001
0 10 (62.5) 3 (10.0)
1 3 (18.8) 9 (30.0)
2 3 (18.8) 9 (30.0)
3 0 (0) 9 (30.0)
Urge incontinence scale 0.003
0 11 (68.8) 6 (20.0)
1 4 (25.0) 7 (23.3)
2 0 (0) 6 (20.0)
3 1 (6.3) 11 (36.7)
Objective success rate 0.789
Cured 15 (93.8) 25 (83.3)
Improved 1 (6.3) 2 (6.7)
Failed 0 (0) 3 (6.5)

* : Mann-Whitney U-test

: Pearson chi-square test,

: Fisher exact test, SUI: stress urinary incontinence, BMI: body mass index, VLPP: Valsalva leak point pressure

Table 2.
Comparison of preoperative and postoperative parameters in patients who voided under 8 times per day
Preoperatively Postoperatively p-value*
No. of 24-hour frequency 6.25±0.93 6.44±1.46 0.971
No. of nocturia 0.44±0.73 0.81±0.83 0.132
Maximum voided volume 396.88±117.63 388.75±145.05 0.874
Frequency scale 0.002
0 5 (31.3) 14 (87.5)
1 6 (37.5) 2 (12.5)
2 4 (25.0) 0 (0.0)
3 1 (6.3) 0 (0.0)
Urgency scale 0.038
0 10 (62.5) 15 (93.8)
1 3 (18.8) 1 (6.3)
2 3 (18.8) 0 (0.0)
3 0 (0.0) 0 (0.0)
Urge incontinence scale 0.034
0 11 (68.8) 16 (100.0)
1 4 (25.0) 0 (0.0)
2 0 (0) 0 (0.0)
3 1 (6.3) 0 (0.0)

* : Wilcoxon signed-rank test

Table 3.
Comparison of preoperative and postoperative parameters in patients who voided 8 or more times per day
Preoperatively Postoperatively p-value*
No. of 24-hour frequency 10.20±2.19 7.80±2.34 <0.001
No. of nocturia 1.30±0.99 0.83±0.70 0.008
Maximum voided volume 301.70±104.79 347.67±83.24 0.005
Frequency scale <0.001
0 0 (0) 17 (56.7)
1 1 (3.3) 10 (33.3)
2 15 (50.0) 2 (6.7)
3 14 (46.7) 1 (3.3)
Urgency scale <0.001
0 3 (10.0) 22 (73.3)
1 9 (30.0) 3 (10.0)
2 9 (30.0) 5 (16.7)
3 9 (30.0) 0 (0.0)
Urge incontinence scale <0.001
0 6 (20.0) 25 (83.30)
1 7 (23.3) 5 (16.7)
2 6 (20.0) 0 (0.0)
3 11 (36.7) 0 (0.0)

* : Wilcoxon signed-rank test

Table 4.
Univariate and multivariate predictors for persistent frequency after TOT
Univariate analysis
Multivariate analysis
OR 95% CI p-value OR 95% CI p-value
Age <50 vs ≥50 0.311 0.080-1.204 0.091 0.149 0.014-1.632 0.119
No. of delivery ≤2 vs >2 1.250 0.348-4.486 0.732 0.849 0.106-6.795 0.877
Previous pelvic surgery no vs yes 5.250 1.184-23.278 0.029 24.817 2.044-301.284 0.012
BMI <25 vs ≥25 0.432 0.118-1.581 0.205 0.728 0.116-4.570 0.735
Maximum voided volume (cc) <300 vs ≥300 0.600 0.155-2.325 0.460 0.515 0.070-3.785 0.514
VLPP (cmH2O) ≥60 vs <60 1.984 0.500-7.867 0.330 1.058 0.078-14.428 0.966
Detrusor overactivity no vs yes 1.733 0.402-7.466 0.460 4.892 0.286-83.604 0.273
Q-tip test (o) <30 vs ≥30 0.600 0.169-2.134 0.430 0.121 0.012-1.240 0.075
Frequency scale 0-1 vs 2-3 0.833 0.204-3.409 0.800 0.202 0.011-3.755 0.283
Urgency scale 0-1 vs 2-3 1.949 0.546-6.953 0.304 0.507 0.023-11.289 0.668
Urge incontinence scale 0-1 vs 2-3 4.600 1.207-17.524 0.025 31.931 1.662-613.619 0.022

TOT: transobturator tape, OR: odds ratio, CI: confidence interval, BMI: body mass index, VLPP: Valsalva leak point pressure

TOOLS
Similar articles